PharVision Advisers »

Alumis shares owned by PharVision Advisers

Quarter-by-quarter ownership of Alumis (ALMS) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Alumis

Tip: Access up to 7 years of quarterly data

All positions including Alumis held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alumis by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $83k 21k 3.99

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding Alumis

AyurMaya Capital Management Company
Foresite Capital Management V
Samsara BioCapital
venBio Partners
Foresite Capital Management VI
BlackRock
Vanguard Group
Nextech Invest
Cormorant Asset Management
Sr One Capital Management
OrbiMed Advisors
Woodline Partners
Baker Bros. Advisors
Tybourne Capital Management
Geode Capital Management

View all funds holding Alumis